人工智能使结直肠息肉可留置原位
该研究在连续结肠镜检查中使用经批准的计算机辅助诊断(CADx)模块,在非放大白光下鉴别腺瘤与非腺瘤,以组织学为金标准。≤5 mm 直肠乙状结肠病变的阴性预测值为 97.6%(95%CI 94.1%-99.1%)。CADx 可能通过减少息肉切除和/或病理负担帮助实施节约成本的结肠镜策略。
要点
- CADx 对≤5 mm 直肠乙状结肠病变的阴性预测值为 97.6%(95%CI 94.1%-99.1%)。
- 295 个≤5 mm 直肠乙状结肠病变中 242 个(82%)适合留置原位策略。
- CADx 与组织学监测间隔在欧洲和美国指南下的一致率分别为 95.6%和 95.9%。
核心结论
- 在本研究中,无需先进影像的 CADx 超过了结直肠息肉光学诊断所需的基准。
- CADx 可能通过减少息肉切除和/或病理负担帮助实施节约成本的结肠镜策略。
研究设计与样本
- 在连续结肠镜检查系列中使用经批准的 CADx 模块,在非放大白光下鉴别腺瘤与非腺瘤。
- 共 162 例患者切除 544 个息肉,其中 295 个(54.2%)为≤5 mm 直肠乙状结肠组织学验证病变。
- 主要结局为 CADx 对≤5 mm 直肠乙状结肠病变腺瘤组织学的阴性预测值。
主要发现
- CADx 诊断在 295 个病变中 291 个(98.6%)可行。
- ≤5 mm 直肠乙状结肠病变的阴性预测值为 97.6%(95%CI 94.1%-99.1%)。
- 295 个病变中 242 个(82%)适合留置原位策略。
- 基于 CADx 输出,544 个息肉中 212 个(39%)适合切除并丢弃策略。
- CADx 与组织学监测间隔在欧洲和美国指南下的一致率分别为 95.6%(95%CI 90.8%-98.0%)和 95.9%(95%CI 89.8%-98.4%)。
关键数值与推荐
- CADx 对≤5 mm 直肠乙状结肠病变腺瘤组织学的阴性预测值为 97.6%(95%CI 94.1%-99.1%)。
- AI 辅助内镜医师对≤5 mm 直肠乙状结肠病变的阴性预测值为 97.6%(95%CI 94.8%-99.1%),CADx 一致诊断率 97.2%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Artificial Intelligence (AI) could support cost-saving strategies for colonoscopy because of its accuracy in the optical diagnosis of colorectal polyps. However, AI must meet predefined criteria to be implemented in clinical settings. METHODS: An approved computer-aided diagnosis (CADx) module for differentiating between adenoma and nonadenoma in unmagnified white-light colonoscopy was used in a consecutive series of colonoscopies. For each polyp, CADx output and subsequent endoscopist diagnosis with advanced imaging were matched against the histology gold standard. The primary outcome was the negative predictive value (NPV) of CADx for adenomatous histology for ≤5-mm rectosigmoid lesions. We also calculated the NPV for AI-assisted endoscopist predictions, and agreement between CADx and histology-based postpolypectomy surveillance intervals according to European and American guidelines. RESULTS: Overall, 544 polyps were removed in 162 patients, of which 295 (54.2%) were ≤5-mm rectosigmoid histologically verified lesions. CADx diagnosis was feasible in 291 of 295 (98.6%), and the NPV for ≤5-mm rectosigmoid lesions was 97.6% (95% CI, 94.1%-99.1%). There were 242 of 295 (82%) lesions that were amenable for a leave-in-situ strategy. Based on CADx output, 212 of 544 (39%) would be amenable to a resect-and-discard strategy, resulting in a 95.6% (95% CI, 90.8%-98.0%) and 95.9% (95% CI, 89.8%-98.4%) agreement between CADx- and histology-based surveillance intervals according to European and American guidelines, respectively. A similar NPV (97.6%; 95% CI, 94.8%-99.1%) for ≤5-mm rectosigmoids was achieved by AI-assisted endoscopists assessing polyps with electronic chromoendoscopy, with a CADx-concordant diagnosis in 97.2% of cases. CONCLUSIONS: In this study, CADx without advanced imaging exceeded the benchmarks required for optical diagnosis of colorectal polyps. CADx could help implement cost-saving strategies in colonoscopy by reducing the burden of polypectomy and/or pathology. CLINICALTRIALS: gov registration number: NCT04884581.
引用
- Hassan C, Balsamo G, Lorenzetti R, et al. Artificial Intelligence Allows Leaving-In-Situ Colorectal Polyps. Clin Gastroenterol Hepatol. 2022. PMID: 35835342. doi:10.1016/j.cgh.2022.04.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。